Treatment‐failure gout: A moving target
Open Access
- 29 August 2008
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (9) , 2587-2590
- https://doi.org/10.1002/art.23803
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinraAnnals of the Rheumatic Diseases, 2007
- Why is gout so poorly managed?Annals of the Rheumatic Diseases, 2007
- PEG-uricase in the management of treatment-resistant gout and hyperuricemiaAdvanced Drug Delivery Reviews, 2007
- Quality of care for gout in the US needs improvementArthritis Care & Research, 2007
- EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2006
- Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and GoutNew England Journal of Medicine, 2005
- Gout epidemiology: results from the UK General Practice Research Database, 1990–1999Annals of the Rheumatic Diseases, 2005
- Relation between adverse events associated with allopurinol and renal function in patients with goutAnnals of the Rheumatic Diseases, 2001
- Uricolytic Activity of Purified Uricase in Two Human BeingsScience, 1957